Abstract
Although a defective vitamin D endocrine system has been widely suspected to be associated in SARS-CoV-2 pathobiology, the status of the vitamin D endocrine system and vitamin D-modulated genes in lung cells of patients infected with SARS-CoV-2 remains unknown. To understand the significance of the vitamin D endocrine system in SARS-CoV-2 pathobiology, computational approaches were applied to transcriptomic datasets from bronchoalveolar lavage fluid (BALF) cells of such patients or healthy individuals. Levels of vitamin D receptor, retinoid X receptor, and CYP27A1 in BALF cells of patients infected with SARS-CoV-2 were found to be reduced. Additionally, 107 differentially expressed, predominantly downregulated genes, as potentially modulated by vitamin D endocrine system, were identified in transcriptomic datasets from patient’s cells. Further analysis of differentially expressed genes provided eight novel genes with a conserved motif with vitamin D-responsive elements, implying the role of both direct and indirect mechanisms of gene expression by the dysregulated vitamin D endocrine system in SARS-CoV-2-infected cells. Protein–protein interaction network of differentially expressed vitamin D-modulated genes were enriched in the immune system, NF-κB/cytokine signaling, and cell cycle regulation as top predicted pathways that might be affected in the cells of such patients. In brief, the results presented here povide computational evidence to implicate a dysregulated vitamin D endocrine system in the pathobiology of SARS-CoV-2 infection.
Similar content being viewed by others
Introduction
COVID19 (SARS-CoV-2) pandemic continues to be a major global public health crisis and has caused 2,649,722 mortalities as of March 15, 20211. The scientific community is being largely guided by the epidemiological, symptomatic, socioeconomic, and population variabilities, and predictive disease models for understanding the cellular basis of infectivity and emerging patterns of the pandemic. This includes the studies of reinfection and/or coinfection with other viruses and formulation of counter measures to minimize the probability of SARS-CoV-2 infection2,3,4. Several recent studies have provided clues about the nature of cellular pathways that might be responsible for the evident population variability in terms of susceptibility, exhibition of symptoms, severity, progression of the disease, and recovery from the infection5,6. This process is further benefitted by applying the lessons gained from the interactions between the human cells and other single-stranded RNA viruses in hosts such as those causing influenza, hepatitis, Ebola, and AIDS.
One of the correlations that has recently gained scientific attention is the correlation between vitamin D deficiency and SARS-CoV-2 infection. This is partly because of the role of vitamin D in cellular phenotypes, including immunity modification and inflammation, and its ability to influence the endothelial cell biology and the functionality of ACE2, one of the major receptors for SARS-CoV-27,8,9. Although correlative studies between vitamin D endocrine system and SARS-CoV-2 continue to provide positive clues about the significance of vitamin D in SARS-CoV-2 pathobiology, the expression status of core components of the vitamin D endocrine system, and hence, the functionality of the pathway in patients infected with SARS-CoV-2 remain unknown.
Vitamin D is one of the most studied steroid hormones with various cellular functions. The precursor vitamin D3 is generated from 7-hydrocholestetol by a nonenzymatic reaction catalyzed by ultraviolet B radiation. In the liver, vitamin D3 is modified to 25-hydroxy vitamin D and further to 1,25-dihydroxyvitamin D (calcitriol) in kidneys as well as in other organ systems in the presence of CYP27B1 enzyme. Cellular effects of vitamin D result from its nongenomic or cytoplasmic effects and/or genomic nuclear effects. They are caused by 1,25-dihydroxy vitamin D binding to the vitamin D receptor (VDR) or retinoid X receptor (RXR) complex within specific responsive DNA sequences in the target genes or through indirect mechanisms9. In addition to the status of vitamin D3/cholecalciferol, biosynthesis of 1,25-dihydroxy vitamin D is positively and negatively modulated by alpha-hydroxylases CYP27B1 and CYP24A1, respectively. Interestingly, these enzymes are under the control of fibroblast growth factor 23 (FGF23), a paracrine growth factor expressed in the lung, heart, and kidney10. Increased systemic levels of FGF23 are generally associated with general inflammation, cardiac hypertrophy, chronic kidney disease, and inflammation in lung airway11; all these phenotypes are found to be closely associated in SARS-CoV-2 pathogenesis. In general, FGF23 acts through its receptors, FGFR1–4, in its coreceptor klotho-dependent or -independent manner. Other activities of FGF23 relevant to SARS-CoV-2 are as follows: participation in cardiac myocytes in stimulating the levels of fibrotic factors, cardiac fibrosis, and pathological cardiac remodeling12; induction of proinflammatory cytokine IL-1beta11; inhibition of ACE2 expression, angiotensin II (Ang II) induction, and blood pressure in kidney13; and inhibition of M1 to M2 transitioning of macrophage and counteracting anti-inflammation response14. Additionally, FGF23 and CYP24A1 are components of a regulatory vitamin D feedback loop because both molecules are genomic targets of 1,25-dihydroxy vitamin D and are stimulated by it in a VDR-dependent manner11,15,16. In addition to vitamin D, FGF23 levels have been shown to be induced by obese growth factor leptin16, master regulator of hypoxia HIF1-alpha17, and proinflammatory TNF-alpha17. For example, leptin induces FGF23 expression and inhibits CYP27B1 expression18, implying a potential compromised status of 1,25-hydroxy vitamin D under conditions of obesity. Recent data suggest that increased levels of inflammatory cytokines in SARS-CoV2 infected patients with a reduced level of vitamin D19. Currently, we do not know the status of FGF23, and other core modifiers of the vitamin D endocrine system in lung cells of patients infected with SARS-CoV-2.
For productive infection, many viruses use the host machinery to antagonize the host defense mechanism while using survival pathways to abort apoptosis for ensuring a successful completion of their replication and generation of progeny virions. In this context, previous work suggest that during the host–RNA-virus interaction, pathogen replication and its propagation are profoundly influenced by human p21-activated kinases (PAKs)20, which are the established modifiers of cytoskeleton remodeling, inflammation, thrombosis, cell survival, and gene expression or repression, in addition to its oncogenic role in cancer development progression21,22,23,24,25. However, to the best of our knowledge, no published data exist about the effect of SARS-CoV-2 on PAK mRNA expression levels in the context of the vitamin D endocrine system. Current data suggest a mechanistic role of PAK-dependent actin polymerization in vitamin D-mediated stimulation of FGF23 expression26; vitamin D signaling stimulates actin depolymerization in endometrial cancer by inhibiting RAC1 and PAK1 expression27; the vitamin D endocrine system uses PAK1 in protecting murine fibroblasts from vitamin E-succinate-triggered apoptosis; and dependency of cholecalciferol-mediated NF-kB transactivation on PAK1 activity28. These examples of regulatory crosstalk between vitamin D and PAKs suggest that the cellular effects of vitamin D in the context of SARS-CoV-2 pathobiology might not be merely affected by the biosynthesis of cholecalciferol but also by the status of FGF23, vitamin D metabolic enzymes, and PAK signaling. However, the status of vitamin D endocrine system in the pathobiology of SARS-CoV-2 infection remains unknown.
To better understand the significance of vitamin D in SARS-CoV-2 pathobiology, we applied computational approaches to study the expression levels of core components and modifiers of the vitamin D endocrine system and to understand its potential relationship with the status of the PAK pathway in SARS-CoV-2-infected individuals.
Results
Status of the vitamin D endocrine system in viral infection model systems
To better understand the significance of the vitamin D endocrine system in the pathobiology of SARS-CoV-2 infection, we first examined the expression levels of core components of the vitamin D endocrine system in various models of viral infection using the Signaling Pathways Project Datasets (SPPD), a collection of transcriptomic datasets initially biocurated by the Nuclear Receptor Signaling Atlas Organization29. As illustrated in Fig. 1, we found evidence of both down- and upregulation of molecules belonging to the vitamin D endocrine system. In general, we noticed a preferential downregulation of the vitamin D endocrine system in majority of the studies compiled in SPPD. We believe that the noted variability in the levels of molecules among various independent biological studies is a common observation and might arise because of differences in the nature and preparation of test samples as well as experimental conditions and reagents used in the different studies. Specifically, we observed reduced expression of vitamin D coreceptors RXRA, CYP27A1, CYP24A1, and FGFR1-4 in most of the SARS virus-derived datasets. However, most of the SPPD datasets lacked information of the vitamin D endocrine system in the SARS-CoV-2 infection model system, except for CYP27B1 upregulation. In general, these observations are consistent with the notion of a general reduced expression of several, but not all, components of the vitamin D endocrine system caused by viruses.
Outlook of Vitamin D components in viral infection models. Expression and distribution of individual genes in Vitamin D component with FDR 5E−02 from vitamin D components under various viral infection models from Signaling Pathway Project.
Suppression of the vitamin D endocrine system in lung cells of patients infected with SARS-CoV-2
To assess the status of the vitamin D endocrine system in lung cells of patients infected with SARS-CoV-2, we next evaluated the levels of core molecules of the vitamin D endocrine system in three separate RNA sequencing-based transcriptomic datasets of bronchoalveolar lavage fluid (BALF) cells from patients with confirmed SARS-CoV-2 infection and in control healthy subjects30,31,32,33, as well as in A549, NHBE, and Calu3 human lung cell lines expressing infected SARS-CoV-231. Our analysis indicated an association between SARS-CoV-2 infection and reduced expression of VDR and its mandatory binding partner RXR and reduced expression of CYP27A1 in two of the three human transcriptomic studies and increased expression of CYP24A1 and reduced expression of FGFR1 in only one of the three SARS-CoV-2-infected patients’ transcriptomic studies (Fig. 2a, Supplementary Table S1). In contrast to the levels of core components of the vitamin D endocrine system in BALF cells from SARS-CoV-2-infected patients, infection associated SARS-CoV-2 overexpression in three lung cancer cells did not alter the expression of most components of the vitamin D endocrine system. However, SARS-CoV-2 overexpression in A549 and Calu3 cells downregulated FGFR1-4 levels (Fig. 2b, Supplementary Table S1). These observations suggest that data from cell lines infected with ectopic overexpression by infection of SARS-CoV-2 may not always be compatible with patient-derived primary cultured cells to understand the significance of the vitamin D endocrine system in SARS-CoV-2-infected patients. Therefore, we focused on transcriptomic data from the patients in subsequent analyses.
Expression profile of genes under SARS-CoV2 infection. (a) Bar chart represents the expression profile of Vitamin D components genes from SARS-CoV-2 infected patient samples30,31,32 (PMID 32407669, PMID 32228226 and GSE147507) when compared to its healthy controls and (b). When the analysis performed in A549, NHBE and Calu3 cell lines from GSE147507.
Vitamin D-modulated genes overlap with differentially expressed genes in lung cells of patients infected with SARS-CoV-2
Vitamin D mediates its biological effects via upregulating or downregulating the expression of cellular genes responsible for various biological processes. Vitamin D modifies the expression of cellular genes either through a direct mechanism involving predicted or validated VDR motifs in the target genes and/or through indirect pathways34,35. Further, we assessed whether noted downregulation of the vitamin D endocrine system in SARS-CoV-2 might also be accompanied by misregulation of vitamin D-modulated genes, and eventually, resultant functions of such gene products. Thus, as illustrated in Fig. 3a, we found a widespread overlap of vitamin D-modulated genes with differentially expressed genes in three transcriptomic datasets from cells of patients infected with SARS-CoV-2. Upon cross-comparing vitamin D-modulated genes that overlapped in SARS-CoV-2 transcriptomic datasets used here, we recognized 43 differentially expressed vitamin D-modulated genes that shared vitamin D dataset and three transcriptomic datasets from lung cells of patients infected with SARS-CoV-2 (Fig. 3b).
Expression of Vitamin D regulated genes in COVID19 patients. (a) Number of genes found overlapped with Vitamin D regulated genes and three SARS-COV-2 datasets are denoted. (b) 43 genes were identified which are common for 3 SARS-COV-2 datasets and also regulated by Vitamin D, (c) Bar diagram shows the summary of enrichment analysis in SARS-COV-2 from Metascape. (d) Bar diagram shows the summary of functional enrichment analysis in from Metascape. (e) The expression status of these 43 genes in SARS-COV-2 patient data is plotted as heat map. (f) Protein–protein interaction network of 19 genes found up-regulated in all three patient dataset and also regulated by Vitamin D isvisualised, The functional enrichment analysis of 19 genes using Reactome identified “Activation of the pre-replicative complex” as primary enrichment (rank 1, hits 9/32 pavlue 3.5e−11), Protein–protein interaction network of 12 genes down-regulated in all three SARS-COV-2 patient transcriptome datasets are also visualised (right side). Genes are found functionally related to immune system (rank 56, 131/1140 p value 1.31e−21) are remarked. The enrichment analysis is performed and network visualization is customized, exported from the Network Analyst tool.
Enrichment analysis of 43 vitamin D-modulated genes in samples collected from COVID patients suggested that many of these genes were downregulated in SARS-CoV-2-infected lung cells31 and CD14+ monocytes36. The associated primary pathways included neutrophil degranulation, regulation of multiorganism processes, and positive regulation of apoptosis37 (Fig. 3c,d). They could potentially influence a whole range of functions in SAR-CoV-2-infected lung cells in a vitamin D-sensitive manner (Supplementary Tables S2, S3). The expression of 15 (about 34%) out of 43 were also observed similarly in three additional datasets used here, namely GSE153970, GSE150316, GSE152075 (Supplementary Figure S1). Expression profiling of these 43 genes indicated that 12 vitamin D-modulated genes (HTT, KCNAB2, EHMT1, RGS3, HEXA, NLRP1, GGA3, MYO1G, ARRB1, PSMD3, MGAT1, and EIF3D) were downregulated in 3 SAR-CoV-2 datasets, 9 genes (SIRPB1, CD4, CTSC, LIPA, PDE4DIP, ITSN1, SSH2, IER2, and HCFC1R1) in 2 datasets, and 3 genes (SECTM1, FOXN3, and GADD45B) in 1 SARS-CoV-2 transcriptomic dataset (Fig. 3e). additionally, Fig. 3e shows the levels of downregulation of 12 genes that overlapped with vitamin D-modulated genes in cells of patients infected with SARS-CoV-2. Protein–protein interaction network analysis of these 12 genes (shown by green circles, Fig. 3f, right) indicated that several of such downregulated genes, such as ARRB1, RGS3, GGA3, HEXA, EIF3D, and PSMD3, are functionally related to the immune system (functional enrichment analysis of network genes using Reactome with a rank of 56, p value 1.31e−21, Supplementary Table S4). Significance of downregulation of these shared 12 genes is judged by the nature of their functions. For example, functions associated with the following genes are expected to be compromised in SARS-CoV-2-infected lung cells: (1) EIF3D, a component of the protein translational complex; reduction in the levels of this component inhibits CD8+ T cell activity and promotes HIV progression38, (2) NLRP1, a component of inflammasome with role in innate immunity39, and (3) RGS3, a G protein signaling component with role in T-lymphocyte motility during T helper 2 (Th2)-driven inflammation in airway cells40.
Among the 43 differentially expressed genes, 19 genes (SLPI, CCL2, STEAP4, FGL2, MARCKS, TMEM71, MXD1, DAPP1, IFITM2, OAS1, SELL, CSTA, CIR1, TIMP1, DYNLT1, IRF2, YWHAE, SCLT1, and NOP10) were upregulated in 3 SARS-CoV-2 datasets; 3 genes (GADD45B, FOXN3, and SECTM1) were upregulated in 2 datasets, and 10 genes (HCFC1R1, IER2, SIRPB1, CD4, CTSC, LIPA, PDE4DIP, ITSN1, and SSH2) were upregulated in 1 dataset (Fig. 3e). Protein–protein interaction network analysis revealed that the upregulated genes were strongly correlated with the immune system. Surprisingly, Reactome pathway enrichment analysis of network of 19 up-regulated genes identified the immune system, cytokine signaling, and adaptive and innate immunity as first four primary enriched gene sets (Fig. 3f, Supplementary Table S5). We found that many of the differentially expressed genes (that overlapped with vitamin D-modulated genes) in the cells of patients infected with SARS-CoV-2 having a role in antiviral responses were induced during viral infection. Interestingly, a subset of differentially expressed 19 genes in lung cells of patients infected with SARS-CoV-2 included genes that have been implicated in the action of interferons, development of antiviral response, and regulation of innate immune responses in individuals and cells infected with viruses41,42,43,44,45,46,47. Examples of such upregulated genes included 2′-5′-oligoadenylate synthetase 1 (OAS1), an interferon-responsive gene48,49,50, interferon regulatory factor 2 (IRF2), interferon-induced transmembrane protein 2 (IFITM2), secretory leukocyte peptidase inhibitor (SLP1), max dimerization protein 1 (MXD1), tissue inhibitor of metalloproteinase-1 (TIMP1), PH domain-containing adaptor Bam32/DAPP1, and T helper type 1 (Th1)/monocyte-associated chemokine CCL2, which have been shown to also participate in SARS-CoV-2–AEC2 signaling in lung cells51. In fact, upregulation of OAS1 and IFITM2 has been recently noticed as a common feature in patients infected with SARS-CoV-241, and certain variants of OAS1 have been predicted to influence SARS-CoV-2 infection52. These observations suggest that the noticed reduced expression of the vitamin D endocrine system in lung cells of patients infected with SARS-CoV-2 could be associated with both down- and upregulation of cellular genes because vitamin D is known to regulate gene expression both positively and negatively. These observations suggested codysregulation of the vitamin D endocrine system with molecules with roles in Th1 response and immune regulation pathways in a subset of patients infected with SARS-CoV-2.
Exploring a potential relationship between SARS-CoV-2 and PAKs
The PAK family of cellular kinases has been found to be activated by pathogens, including RNA viruses such as influenza and HIV53,54. Over the years, PAKs have been implicated in various stages of virus entry and replication and in supporting the cell survival phenotype during certain viral infections20. To understand the significance of the PAK pathway in SARS-CoV-2 pathobiology, we first examined the status of PAKs in SPPD. We found that the levels of PAK1 and PAK4 mRNAs are generally upregulated in model systems pertaining to middle east respiratory syndrome coronavirus (MERSCOV), whereas PAK2 and PAK3 are downregulated in MERSCOV models (Fig. 4a).
Expression of PAKs in viral infection models. (a) Shows the fold change distribution of p21 activated kinases with an FDR cut-off of 5E-02 from viral infection from Signaling Pathway Project. (b) Shows the expression levels of kinases in SARS-COV-2 patient samples.
Further, we examined the levels PAK1–4 in transcriptomic analyses in lung cells of patients infected with SARS-CoV-2. We noticed PAK1 mRNA upregulation in datasets of all three patients infected with SARS-CoV-2. No significant alteration was observed in the differential expression of PAK2, PAK3 and PAK4 in samples collected from patients infected with SARS-CoV-2 compared with the healthy controls (Fig. 4b). In addition to PAK kinases, cell survival is known to be profoundly regulated by AKT kinases55,56. However, as opposed to PAKs, we noticed a reduction in AKT levels in SARS-CoV-2-infected cells (Fig. 4b). These observations suggested an association between the levels of PAK1 mRNA and SARS-CoV-2 infection. However, the current literature provides no clues about the role of PAK expression in the pathobiology of SARS-CoV-2 infection.
A subset of differentially expressed genes in SARS-CoV-2-infected lung cells are shared targets of PAK- and vitamin D-modulated genes
Our finding of a compromised expression of several components of the vitamin D endocrine system and increased PAK1 expression in the same transcriptomic analyses of lung cells of patients infected with SARS-CoV-2 raised a possibility of an association between these two phenomena. We attempted to explore this possibility. In this context, previous studies have suggested a role of PAK-dependent modulation of actin polymerization in the regulation of FGF2326,27, a modifier of CYP27B1 and CYP24A1 in the vitamin D endocrine system, and the vitamin D endocrine system have been suggested to inhibit the levels of RAC (a positive regulator of PAK1 activation) in endometrial cancer cells27. A recent review article57 has speculated the possibility of PAK1 regulation of CCL2, a molecule shown to connect ACE2 with liver fibrosis in a murine model58, during SARS-CoV-2 infection. However, data supporting a connection between PAK1 and SARS-CoV-2 pathways remained uninvestigated until this point.
Because we observed a compromised vitamin D endocrine system and increased PAK1 expression in the SARS-CoV-2 transcriptome, we further searched for genes that might be common effectors of vitamin D and PAK pathways. Figure 5a shows that indeed there is a widespread overlap of genes common to vitamin D- and PAK-regulated genes. Our analysis identified 563 differentially expressed genes common to vitamin D- and PAK-regulated datasets (Fig. 5b). The expression levels of the two sets of genes are depicted in the heatmap (Fig. 5c). We next searched 563 differentially expressed genes for vitamin D-modulated genes that might be downregulated or upregulated in SARS-CoV-2 transcriptome, presumably because of a compromised vitamin D endocrine system or gene expression due to derepression. We believe that such genes might be the shared effectors of vitamin D and PAK pathways in lung cells of patients infected with SARS-CoV-2, and hence, they might be involved in SARS-CoV-2 pathobiology.
Shows the overlap between Vitamin D regulated genes and PAK regulated genes. (a) Venn diagram shows the comparison of Vitamin D target genes for each PAK datasets and the overlapped genes are denoted using Venn diagram. (b) Venn diagram shows the overlap between Vitamin D regulated genes and PAK regulated genes. Vitamin D regulated genes are selected from RNA-Seq data from the given PubMed identification numbers (Ids). Statistically significant genes which shown positive correlation up on PAK1 silencing and up on PAK4 over expression from given studies are considered as PAK regulated genes and a pie chart shows the number of genes selected from each PAK studies. (c) The heat map shows the expression of 40 genes down regulated in 2 out of 3 SARS-COV-2 patient samples and the 24 genes found down regulated in 2 out of 3 SARS-COV-2 patient samples.
We focused on vitamin D-modulated genes that were downregulated in two out of three SARS-CoV-2 transcriptomic studies. Our analysis identified 40 such downregulated genes out of 563 differentially expressed genes, shared between vitamin D and PAK pathways, in SARS-CoV-2-infected lung cells (Fig. 5b). Similarly, there are 24 upregulated genes (shared between vitamin D and PAK pathways) in SARS-CoV-2-infected lung cells (Fig. 5b). These observations suggest that the evident dysregulated vitamin D endocrine system in SARS-CoV-2-infected lung cells could be accompanied by both down- and upregulation of downstream effectors that are also shared effectors of the PAK1 pathway in SARS-CoV-2-infected lung cells. Because SARS-CoV-2 induces PAK1 expression in lung cells and PAK1 signaling stimulates as well as represses several cellular genes21,22,23,24,25, a subset of genes in SARS-CoV-2 infected cells might be coinfluenced by a defective vitamin D and viral infection-associated PAK1 upregulation.
Vitamin D endocrine system and SARS-CoV-2 pathogenesis
Aforementioned analysis identified 43 vitamin D-modulated genes dysregulated in lung cells of patients infected with SARS-CoV-2. Protein–protein interaction network analysis of 43 genes revealed that many of these genes are functionally related to NF-κB pathway and cytokine signaling, DNA damage checkpoint and response (rank 2 and 3), and apoptosis (rank 4) (Fig. 6a). Similarly, protein–protein interaction network analysis of 40 downregulated genes, which were shared targets of vitamin D and PAK pathways, in SARS-CoV-2-infected lung cells indicated that genes in the top four rank orders belong to different aspects of regulation of immune response (Fig. 6b). In contrast to the aforementioned downregulated genes, protein–protein interaction network analysis of 24 upregulated genes, which were shared targets of vitamin D and PAK pathways, suggested cell cycle regulation and gene expression as the top functional targets (Fig. 6c). These observations raised the possibility that the evident downregulation of vitamin D and upregulation of PAK1 in SARS-CoV-2-infected cells is likely to have a significant influence upon NF-κB pathway, cytokine signalling and immune regulation. The critical role of genes important for promoting the G1–S progression as well as key components of the cell survival that could impact the pathobiology of SARS-CoV-2 is also evident in the analysis. Further studies are warranted to delineate the mechanism underlying these findings with a broad implication in the pathobiology of SARS-CoV-2.
Protein–protein interaction network of vitamin D-modulated differentially expressed genes in SARS-CoV-2 transcriptome using Network analyst tool. (a) Protein–protein interaction network 40 genes shared with Vitamin D and PAK regulated genes which are down regulated in at least two SARS-COV-2 datasets were visualised. (b) Protein–protein interaction network of 43 genes shared among all 3 SARS-COV-2 datasets and Vitamin D regulated genes are visulaised and the genes belong to Immune system is remarked (rank 1). (c) Protein–protein interaction network of 24 genes shared with Vitamin D and PAK regulated genes which are up-regulated in at least two SARS-COV-2 datasets are visualised. *Results of functional enrichment analysis using Reactome is provided in the table. Pathways for the first four ranks are listed with each network.
Targets of the dysregulated vitamin D endocrine system with or without VDR in SARS-CoV-2-infected lung cells
The vitamin D endocrine system exerts its cellular effects through nongenomic/cytoplasmic and nuclear effects. Vitamin D regulates the expression of cellular genes either through modifying the expression of target genes containing vitamin D responsive elements (VDR) or indirect mechanisms as a consequence of other effects of vitamin D. VDR as a heterodimer protein complex with receptor RXR binding to the DR3-response element consisting of A/GGG/TTC/GA motif34,59. We next searched for the presence of VDR motifs within − 1000 bp and − 100 bp from TSS in target gene promoters among 43 differentially expressed vitamin D-modulated genes and 40 differentially expressed genes between vitamin D modulated and PAK pathways in the SARS-CoV-2-infected transcriptome. Surprisingly, we found the presence of VDR motifs in 3 of the 43 differentially expressed genes (JAG1, ST3GAL1, and ZNF589) and in 5 of the 40 differentially expressed genes (ITSN1, GADD45B, PDE4DIP, HTT, and MARCKS) in SARS-CoV-2-infected cells (Fig. 7a,b). These observations suggest that a defective vitamin D endocrine system could impact the levels of differential expression of vitamin D-modulated genes in SARS-CoV-2-infected lung cells via both direct mechanisms involving the VDR motif in the target genes and indirect mechanisms.
Analysis of postulated vitamin D target genes. (a) Status of VDR binding motifs, shared histone marks and TFs in TSS as well as enhancer regions. (a) Results when the analysis carried out for genes with VDR binding motifs. (b) Expression level of the genes in SARS-CoV-2 patient datasets are provided.
Discussion
In brief, the present study was conducted to assess the status of the vitamin D endocrine system in patients infected with SARS-CoV-2 using public transcriptomic datasets and computational approaches. Results presented support the notion of a potential association between SARS-CoV-2 infection and reduced expression of several components of the vitamin D endocrine system. As expected, the dysregulated vitamin D endocrine system in the lung cells of patients infected with SARS-CoV-2 was accompanied by dysregulation (both down- and upregulation) of cellular genes of vitamin D-modulated genes, including molecules involved in Th1 response and immune regulation. Another novel notable observation is the upregulation of PAK1 expression (but not another family of survival AKT kinases) in the same SARS-CoV-2 sample sets with a reduced expression of vitamin D endocrine system components, suggesting a potential correlative relationship between these two phenomena. Consistent with this hypothesis, we noticed that indeed a subset of differentially expressed genes in lung cells of patients infected with SARS-CoV-2 is also the shared target of PAK- and vitamin D-modulated genes and such genes were coinfluenced by not only a defective vitamin D endocrine system but also PAK1 upregulation associated with SARS-CoV-2-infection; thus, they are involved in SARS-CoV-2 pathobiology. Future studies are required to define the precise levels of crosstalk between PAK1 and vitamin D endocrine system and to determine whether PAK1 plays a role in the dysregulated vitamin D endocrine system.
As vitamin D modulates the expression of several cellular genes through a direct mechanism involving VDR motifs in the putative target genes as well as through indirect mechanisms, we observed that most differentially expressed genes, common to vitamin D and/or PAK-modulated genes, in SARS-CoV-2-infected lung cells lacked the VDR motif in target gene promoters. Hence, they were expected to be regulated by indirect mechanisms in SARS-CoV-2-infected cells by vitamin D. However, our analysis did discover, at least, eight new vitamin D target genes with a conserved VDR motif within − 1000 and − 100 from TSS in gene promoters as differentially expressed genes in SARS-CoV-2-infected lung cells. This raised the possibility of direct mechanisms of regulation of such vitamin D-modulated genes by the dysregulated vitamin D endocrine system.
To highlight the potential significance of a subset of eight newly recognized VDR-containing target genes in SARS-CoV-2 pathobiology, we here briefly discuss the potential connection between six differentially expressed genes in SARS-CoV-2-infected lung cells; however, ZNF589 and HTT remained novel in the context of viral infection.
Intersectin-1 (ITSN1)
Cytoskeleton remodeling and interactions, including dynamics of actin polymerization–depolymerization, which is a process also regulated by PAK signaling21, plays a role in the early steps of endocytosis during viral infection and phagocytosis60,61. One such regulator is the guanine nucleotide exchange factor ITSN1 with an established role in vaccinia infection-associated actin polymerization and Fc-gamma receptor-mediated phagocytosis62. In the context of SARS-CoV-2 infection, actin remodeling represents a central event in inflammatory responses in the lungs63 and might be involved in virus entry64. Further, components of actin remodeling have emerged as important interactors of membranous ACE265, which is the primary receptor for SARS-CoV-2. Likewise, Fc-gamma-mediated phagocytosis, a process known to be regulated by ITSN1, plays an important role in immune responses during SARS-CoV-2 infection66. These observations in conjunction with the identification of ITSN1 as one of the vitamin D-modulated differentially expressed genes in SARS-CoV-2-infected lung cells further raise the possibility of connecting a dysregulated vitamin D endocrine system with misregulation of any of the aforementioned cellular functions of ITSN1.
Growth arrest and DNA damage inducible beta (GADD45B)
GADD45B and GADD45A have been shown to be important in the regulation of DNA damage response and senescence67. Relevance of the presence of a conserved VDR motif in the promoter region of GADD45B and its differential expression in SARS-CoV-2-infected lung cells (as shown in this study) lies in a recent finding presenting the differential expression of GADD45B as well as other genes belonging to mitochondrial functions in patients with chronic obstructive pulmonary disease (COPD)68. Further, as older patients with COPD are more susceptible to SARS-CoV-2 infection69, GADD45B might be involved in SARS-CoV-2 pathobiology in patients with COPD.
Phosphodiesterase 4D-interacting protein (PDE4DIP)
PDE4DIP is an understudied enzyme that hydrolyzes the 3′ cyclic phosphate linkages in 3′,5′-cAMP and cGMP and 3′,5′-cAMP and participate in cellular signaling and other processes70. PDE4DIP has recently been suggested to be a differentially expressed genes in lung cells in COPD71. As no precedence of vitamin D regulation of PDE4DIP exists, our present finding indicates the possibility of a regulatory relationship between vitamin D and cyclin AMP or GMP signaling in SARS-CoV-2 pathobiology in lung cells.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1)
ST3GAL1 is an enzyme with sialyltransferase activity. It participates in transferring sialic acid to substrates with galactose as the acceptor and is involved in glycosylation21. Glycosylation is fundamental to the regulation of numerous cellular processes, including vitamin D-binding proteins72. As certain genetic variants of ST3GAL1 have been shown to be associated with an increased probability of severity in patients with influenza A(H1N1)pdm09 infection73, the dysregulated vitamin D endocrine system in SARS-CoV-2-infected patients might be accompanied by misglycosylation of certain proteins, which in turn may impact SARS-CoV-2 pathobiology in lung cells.
Jagged-1 (JAG1)
Activation of Notch receptors by Notch ligands, including JAG1, and resulting signaling events have been shown to be involved in cell-to-cell communication. In addition, JAGs/Notch signaling influences diverse aspects of cytokine biology, inflammation, dendritic cell biology, T-cell development, B-cell repertoire, and innate immunity74,75,76,77. Further, Notch signaling has been suggested to be downstream of IL6, which is a proinflammatory cytokine with a role in the inflammatory storm, in the lung and heart78. In the context of viral infection, JAG1/Notch 1 signaling participates in the development of Th2 response in bronchial epithelial cells following infection with respiratory syncytial infection79. Interestingly, experimental downregulation of JAG1has been shown to promote Th1 response while suppressing Th2 differentiation, a situation similar to that observed in SARS-CoV-2-infected lung cells in this study79. This situation is also somewhat similar to that of SARS-CoV-2-specific CD4+ T cells and is shown to be Th1 type80. These observations and the finding in this study that JAG1 could be a vitamin D-regulated gene suggest that a dysregulated vitamin D endocrine system might influence cellular immunity via the JAG1 pathway.
Myristoylated alanine-rich C kinase substrate (MARCKS)
MARCKS, a substrate of protein kinase C and actin-interacting protein, is present in the plasma membrane. It modulates vascular contractility and regulates Ca2+ and phosphatidylinositol 4,5-bisphosphate signaling81. Upon activation by PKC signaling, MARCKS translocates from the plasma membrane to the cytoplasm and regulates many cellular processes depending on actin remodeling, such as membrane trafficking and phagocytosis. MARCKS has been shown to be involved in lung diseases, including COPD and asthma82, probably because of its ability to regulate mucin secretion and inflammation83. Activation of PKC, either directly or through secreted cytokines, is generally viewed a common event during viral infections, including human immunodeficiency virus in promonocytic cells, respiratory syncytial virus in bronchial epithelial cells84,85, and hepatitis B virus transactivator HBx86. Additionally, Ang II has been shown to activate PKC-β, and in turn, cellular redistribution of MARCKS in neurons87. Vitamin D3 metabolites are known activators of PKC, and vitamin D deficiency is associated with a dysregulated subcellular distribution of PKC isoforms in rat colonocytes88. The aforementioned observations suggest that a defective vitamin D endocrine system might be associated with a misregulated subcellular distribution of MARCKS in lung cells and could be involved in SARS-CoV-2 pathobiology.
In brief, this study provides insights about a potentially causal association between a compromised vitamin D endocrine system at multiple levels and SARS-CoV-2 infections in patients, and consequently, dysregulation of pathways downstream to vitamin D. These preliminary results now set the stage for experimental validation of the observations and postulations made using computational approaches. Additionally, this study also sets the stage for conducting a larger study to determine whether a compromised vitamin D endocrine systemmight influence the susceptibility of lung cells to SARS-CoV-2 and/or the consequence of SARS-CoV-2 infection.
Methods
Gene expression profiling in viral infection models
Relative transcript abundance for individual genes were analyzed using Ominer tool from The Signaling Pathways Project89,90. Single gene target was analyszed under transcriptomics category. An FDR cut-off of 5E-02 was applied for the analysis, expression profiles for viral infection models were extracted and represented in the article.
SARS-CoV-2 lung patient transcriptome
High throughput transcriptomic data for SARS-COV-2 patient samples were selected from the studies submitted under studies related to SARS-CoV-2 in Gene Expression Omnibus up to July 2020, wherein first study performed a transcriptomic profiling of bronchoalveolar lavage fluid (BALF) was performed on SARS-CoV-2 patient samples and healthy donors from Zhongnan Hospital of Wuhan University32. Second study reports that BALF cell transcriptome indicates robust innate immune responses in SARS-CoV-2 patients30 and the remaining studies provided the transcriptomic data of SARS-CoV-2 deceased patients, the data has accessed from Gene Expression Omnibus under the accession GSE147507.
SARS-COV-2 lung cell line transcriptome
The transcriptome data of primary human lung epithelium (NHBE), transformed lung alveolar (A549), transformed lung-derived Calu-3 cells mock treated or infected with SARS-CoV-2 (USA-WA1/2020), data was accessed from Gene Expression Omnibus under the accession GSE14750731. In a multi sampled study, samples were selected only for SARS-COV-2 cell line and differential expression analysis was performed with respect to corresponding control cell line.
PAK silenced transcriptome data
The gene expression profiles of MCF10A.B2 cells (MCF10A cells expressing a chemically activatable form of Her2) stably expressing a Tet inducible shRNA directed against Pak1 gene was accessed from Gene Expression Omnibus under the accession GSE7128391. Differentially expressed genes were obtained using GEO2R, an interactive web tool available with Gene Expression Omnibus. GEO2R uses GEOquery and limma R packages from the Bioconductor project to identify differentially expressed genes.
Differential expression analysis and data
Differential expression data available as supplementary data were collected from two studies, The first study32 called differentially expressed genes using DESeq2 package (v1.26.0)92 and the second study30 used the limma package93 (v3.42.2) from BioconductorDifferential expression analysis was performed using BioJupies94 for the gene count data provided under the accession GSE147507, BioJupies94 determines differentially expressed genes using the limma package v3.42.2(ref). Differentially expressed genes for the cell lines infected with SARS-COV-2 with respect to corresponding control was obtained, and genes were considered for analysis form all the samples if they show a fold-change of at least 1.5 and also satisfy p value < 0.05.
Functional enrichment analysis
We have performed Gene Enrichment analysis for the 43 genes identified in common with Vitamin D regulated genes and PAK regulated genes using Metascape37. Gene symbols are used as input to perform the enrichment and analysis species as Homo Sapiens. An express enrichment analysis was performed for given gene list with default parameters. The analysis involves enrichment for multiple pathways, data sets and COVID. All genes in the genome have been used as the enrichment background. Terms with a p value < 0.01, a minimum count of 3, and an enrichment factor > 1.5. The top-level Gene Ontology biological processes results and Summary of enrichment analysis in COVID were exported.
Protein–protein interaction network and enrichment analysis
Generic protein–protein interactions of gene sets (official gene symbol) were obtained from using IMEx Interactome95 and default confidence score cutoff (900) and the Corresponding gene cluster was analysed for biological pathway involvement using functional explorer based on Reactome database96. Protein–protein interaction network visualization for the set of genes were performed using Network Analyst 3.0 tool97,98,99.
References
W. H. Organization. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int (2020).
Mehraeen, E. et al. Predictors of mortality in patients with COVID-19—a systematic review. Eur. J. Integr. Med. 40, 101226 (2020).
Holtz, D. et al. Interdependence and the cost of uncoordinated responses to COVID-19. Proc. Natl. Acad. Sci. USA 117, 19837–19843 (2020).
Harrison, A. G., Lin, T. & Wang, P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. https://doi.org/10.1016/j.it.2020.10.004 (2020).
Abdelzaher, H. et al. COVID-19 genetic and environmental risk factors: A look at the evidence. Front. Pharmacol. 11, 579415 (2020).
Fartushok, T. COVID-19: Topical issues of clinic activities during a pandemic. Georgian Med. News 20, 122–132 (2020).
Zemb, P. et al. Vitamin D deficiency and COVID-19 pandemic. J. Glob. Antimicrob. Resist. 22, 133–134 (2020).
Marik, P. E., Kory, P. & Varon, J. Does vitamin D status impact mortality from SARS-CoV-2 infection?. Med. Drug Discov. 6, 100041 (2020).
Norman, P. E. & Powell, J. T. Vitamin D and cardiovascular disease. Circ. Res. 114, 379–393 (2014).
Edmonston, D. & Wolf, M. FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nat. Rev. Nephrol. 16, 7–19 (2020).
Krick, S. et al. Fibroblast growth factor 23 and Klotho contribute to airway inflammation. Eur. Respir. J. 52, 20 (2018).
Leifheit-Nestler, M. & Haffner, D. Paracrine EFFECTS of FGF23 on the heart. Front. Endocrinol. (Lausanne) 9, 278 (2018).
Vaidya, A. & Williams, J. S. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 61, 450–458 (2012).
Han, X. et al. Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages. FEBS Lett. 590, 53–67 (2016).
Kumar, A., Adhikary, A., Shamoun, L. & Sevilla, M. D. Do solvated electrons (e(aq)−) reduce DNA bases? A Gaussian 4 and density functional theory-molecular dynamics study. J. Phys. Chem. B 120, 2115–2123 (2016).
Saini, R. K. et al. 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: Evidence for primary and secondary mechanisms modulated by leptin and interleukin-6. Calcif. Tissue Int. 92, 339–353 (2013).
Francis, C. & David, V. Inflammation regulates fibroblast growth factor 23 production. Curr. Opin. Nephrol. Hypertens. 25, 325–332 (2016).
Upp, J. R. J. et al. Inhibition of human gastric adenocarcinoma xenograft growth in nude mice by alpha-difluoromethylornithine. Cancer Res. 48, 3265–3269 (1988).
Tsuji, K., Maeda, T., Kawane, T., Matsunuma, A. & Horiuchi, N. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J. Bone Miner. Res. 25, 1711–1723 (2010).
John Von Freyend, S. et al. Subverting host Cell P21-activated kinase: A case of convergent evolution across pathogens. Pathog. (Basel, Switzerland) 6, 20 (2017).
Kumar, R., Gururaj, A. E. & Barnes, C. J. p21-activated kinases in cancer. Nat. Rev. Cancer 6, 459–471 (2006).
Kumar, A. et al. PAK thread from amoeba to mammals. J. Cell. Biochem. 107, 579–585 (2009).
Molli, P. R., Li, D. Q., Murray, B. W., Rayala, S. K. & Kumar, R. PAK signaling in oncogenesis. Oncogene 28, 2545–2555 (2009).
Kumar, R., Sanawar, R., Li, X. & Li, F. Structure, biochemistry, and biology of PAK kinases. Gene 605, 20–31 (2017).
Kumar, R. & Li, D.-Q. PAKs in human cancer progression: From inception to cancer therapeutic to future oncobiology. Adv. Cancer Res. 130, 137–209 (2016).
Fajol, A. et al. Fibroblast growth factor (Fgf) 23 gene transcription depends on actin cytoskeleton reorganization. FEBS Lett. 590, 705–715 (2016).
Zeng, N. et al. 1α,25(OH)2D3 induces actin depolymerization in endometrial carcinoma cells by targeting RAC1 and PAK1. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 40, 1455–1464 (2016).
Adams, L. S. & Teegarden, D. 1,25-dihydroxycholecalciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor kappaB. J. Nutr. 134, 2948–2952 (2004).
The Signaling Pathways Project. https://www.signalingpathways.org/index.jsf.
Zhou, Z. et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27, 883-890.e2 (2020).
Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036-1045.e9 (2020).
Xiong, Y. et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg. Microbes Infect. 9, 761–770 (2020).
Blanco-Melo, D. et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. bioRxiv https://doi.org/10.1101/2020.03.24.004655 (2020).
Nurminen, V., Seuter, S. & Carlberg, C. Primary vitamin D target genes of human monocytes. Front. Physiol. 10, 194 (2019).
Einarsdottir, E. et al. A preliminary transcriptome analysis suggests a transitory effect of vitamin D on mitochondrial function in obese young Finnish subjects. Endocr. Connect. 8, 559–570 (2019).
Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070–1076 (2020).
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).
Pan, Y. et al. Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function. J. Transl. Med. 17, 167 (2019).
Creagh, E. M. & O’Neill, L. A. J. TLRs, NLRs and RLRs: A trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27, 352–357 (2006).
Williams, J. W. et al. RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L693-701 (2013).
Lieberman, N. A. P. et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLOS Biol. 18, e3000849 (2020).
Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623–655 (2001).
Siegrist, F., Ebeling, M. & Certa, U. The small interferon-induced transmembrane genes and proteins. J. Interf. Cytokine Res. 31, 183–197 (2011).
Lepargneur, J.-P. & Abbal, M. Innate and adaptative immunity of the female genital tract. J. Gynecol. Obstet. Biol. Reprod. (Paris) 41, 612–622 (2012).
Allen, J. R. et al. TIMP-1 promotes the immune response in influenza-induced acute lung injury. Lung 196, 737–743 (2018).
Fournier, E. et al. The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr. Biol. 13, 1858–1866 (2003).
Thoutam, A., Breitzig, M., Lockey, R. & Kolliputi, N. Coronavirus: A shift in focus away from IFN response and towards other inflammatory targets. J. Cell Commun. Signal. https://doi.org/10.1007/s12079-020-00574-3 (2020).
Kumar, R., Tiwari, R. K., Kusari, J. & Sen, G. C. Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons. J. Virol. 61, 2727–2732 (1987).
Kumar, R., Choubey, D., Lengyel, P. & Sen, G. C. Studies on the role of the 2’-5’-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication. J. Virol. 62, 3175–3181 (1988).
Kumar, R., Chattopadhyay, D., Banerjee, A. K. & Sen, G. C. Ribonuclease activity is associated with subviral particles isolated from interferon-treated vesicular stomatitis virus-infected cells. J. Virol. 62, 641–643 (1988).
Chen, I.-Y. et al. Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J. Virol. 84, 7703–7712 (2010).
Klaassen, K. et al. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection. Infect. Genet. Evol. 84, 104498 (2020).
Pascua, P. N. Q. et al. Role of the p21-activated kinases (PAKs) in influenza A virus replication. Biochem. Biophys. Res. Commun. 414, 569–574 (2011).
Nunn, M. F. & Marsh, J. W. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70, 6157–6161 (1996).
Linton, M. F., Moslehi, J. J. & Babaev, V. R. Akt signaling in macrophage polarization, survival, and atherosclerosis. Int. J. Mol. Sci. 20, 20 (2019).
Hinz, N. & Jücker, M. Distinct functions of AKT isoforms in breast cancer: A comprehensive review. Cell Commun. Signal. 17, 154 (2019).
Maruta, H. & He, H. PAK1-blockers: Potential therapeutics against COVID-19. Med. Drug Discov. 6, 100039 (2020).
Lu, S. et al. PTEN (phosphatase and Tensin Homolog) protects against Ang II (Angiotensin II)-induced pathological vascular fibrosis and remodeling-brief report. Arterioscler. Thromb. Vasc. Biol. 40, 394–403 (2020).
Carlberg, C. et al. Two nuclear signalling pathways for vitamin D. Nature 361, 657–660 (1993).
Dergai, O. et al. The LMP2A protein of Epstein–Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases. Cell. Signal. 25, 33–40 (2013).
Chenoweth, A. M., Wines, B. D., Anania, J. C. & Mark Hogarth, P. Harnessing the immune system via FcγR function in immune therapy: A pathway to next-gen mAbs. Immunol. Cell Biol. 98, 287–304 (2020).
Humphries, A. C., Donnelly, S. K. & Way, M. Cdc42 and the Rho GEF intersectin-1 collaborate with Nck to promote N-WASP-dependent actin polymerisation. J. Cell Sci. 127, 673–685 (2014).
Du, L. et al. Actin filament reorganization is a key step in lung inflammation induced by systemic inflammatory response syndrome. Am. J. Respir. Cell Mol. Biol. 47, 597–603 (2012).
Veljkovic, V., Vergara-Alert, J., Segalés, J. & Paessler, S. Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: Prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target. F1000Research 9, 52 (2020).
Chirinos, J. A. et al. Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure. Hypertens. (Dallas, Tex. 1979) 76, 1526–1536 (2020).
Pierce, C. A. et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl. Med. 12, 20 (2020).
Schmitz, I. Gadd45 proteins in immunity. Adv. Exp. Med. Biol. 793, 51–68 (2013).
Maremanda, K. P., Sundar, I. K., Li, D. & Rahman, I. Age-Dependent assessment of genes involved in cellular senescence, telomere, and mitochondrial pathways in human lung tissue of smokers, COPD, and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-furin-DPP4 axis. Front. Pharmacol. 11, 584637 (2020).
Zhao, Q. et al. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J. Med. Virol. https://doi.org/10.1002/jmv.25889 (2020).
Shapshak, P. Molecule of the month, PDE4DIP. Bioinformation 8, 740–741 (2012).
Heinbockel, L. et al. Identification of novel target genes in human lung tissue involved in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 13, 2255–2259 (2018).
Kilpatrick, L. E. & Phinney, K. W. Quantification of total vitamin-D-binding protein and the glycosylated isoforms by liquid chromatography-isotope dilution mass spectrometry. J. Proteome Res. 16, 4185–4195 (2017).
Maestri, A. et al. Siaα2-3Galβ1-receptor genetic variants are associated with influenza A(H1N1)pdm09 severity. PLoS One 10, e0139681 (2015).
Tchekneva, E. E. et al. Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity. J. Immunother. Cancer 7, 95 (2019).
Cahill, E. F., Tobin, L. M., Carty, F., Mahon, B. P. & English, K. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells. Stem Cell Res. Ther. 6, 19 (2015).
Cruickshank, M. N. & Ulgiati, D. The role of notch signaling in the development of a normal B-cell repertoire. Immunol. Cell Biol. 88, 117–124 (2010).
Shang, Y., Smith, S. & Hu, X. Role of Notch signaling in regulating innate immunity and inflammation in health and disease. Protein Cell 7, 159–174 (2016).
Rizzo, P. et al. COVID-19 in the heart and the lungs: Could we ‘Notch’ the inflammatory storm?. Basic Res. Cardiol. 115, 31 (2020).
Qin, L. et al. Bronchial epithelial cells promote the differentiation of Th2 lymphocytes in airway microenvironment through jagged/notch-1 signaling after RSV infection. Int. Arch. Allergy Immunol. 179, 43–52 (2019).
Neidleman, J. et al. SARS-CoV-2-specific T cells exhibit phenotypic features of helper function, lack of terminal differentiation, and high proliferation potential. Cell Rep. Med. 1, 100081 (2020).
Jahan, K. S. et al. MARCKS mediates vascular contractility through regulating interactions between voltage-gated Ca(2+) channels and PIP(2). Vasc. Pharmacol. 132, 106776 (2020).
Sheats, M. K. et al. MARCKS and lung disease. Am. J. Respir. Cell Mol. Biol. 60, 16–27 (2019).
Green, T. D., Crews, A. L., Park, J., Fang, S. & Adler, K. B. Regulation of mucin secretion and inflammation in asthma: A role for MARCKS protein?. Biochim. Biophys. Acta 1810, 1110–1113 (2011).
Kinter, A. L., Poli, G., Maury, W., Folks, T. M. & Fauci, A. S. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J. Virol. 64, 4306–4312 (1990).
San-Juan-Vergara, H., Peeples, M. E., Lockey, R. F. & Mohapatra, S. S. Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells. J. Virol. 78, 13717–13726 (2004).
Luber, B. et al. The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C. Res. Virol. 144, 311–321 (1993).
Lu, D., Yang, H., Lenox, R. H. & Raizada, M. K. Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons. J. Cell Biol. 142, 217–227 (1998).
Bissonnette, M. et al. 1,25-Dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol 13-acetate cause differential activation of Ca(2+)-dependent and Ca(2+)-independent isoforms of protein kinase C in rat colonocytes. J. Clin. Invest. 95, 2215–2221 (1995).
Becnel, L. B. et al. Discovering relationships between nuclear receptor signaling pathways, genes, and tissues in transcriptomine. Sci. Signal. 10, 20 (2017).
Ochsner, S. A. et al. The signaling pathways project, an integrated ’omics knowledgebase for mammalian cellular signaling pathways. Sci. Data 6, 252 (2019).
Villamar Cruz, O. et al. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition. Oncotarget 7, 76590–76603 (2016).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
Torre, D., Lachmann, A. & Ma’ayan, A. BioJupies: Automated generation of interactive notebooks for RNA-Seq data analysis in the cloud. Cell Syst. 7, 556-561.e3 (2018).
Breuer, K. et al. InnateDB: Systems biology of innate immunity and beyond–recent updates and continuing curation. Nucleic Acids Res. 41, D1228–D1233 (2013).
Fabregat, A. et al. Reactome diagram viewer: Data structures and strategies to boost performance. Bioinformatics 34, 1208–1214 (2018).
Zhou, G. et al. NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 47, W234–W241 (2019).
Xia, J., Gill, E. E. & Hancock, R. E. W. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat. Protoc. 10, 823–844 (2015).
Xia, J., Benner, M. J. & Hancock, R. E. W. NetworkAnalyst-integrative approaches for protein-protein interaction network analysis and visual exploration. Nucleic Acids Res. 42, W167–W174 (2014).
Acknowledgements
Bijesh George and Aswathy Mary Paul are supported by fellowships from the Rajiv Gandhi Centre for Biotechnology.
Author information
Authors and Affiliations
Contributions
R.K. conceived, designed, and supervised the study; R.K. and M.R.P. analyzed the data; R.K. wrote the first draft, M.R.P. and T.R.S.K. edited the draft manuscript. B.G. performed bulk of the computational studies; A.M.P. performed PubMed analysis; and A.R. analyzed promoters of select differentially expressed genes; and lead study contact, R.K. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
George, B., Amjesh, R., Paul, A.M. et al. Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient’s lung cells. Sci Rep 11, 8570 (2021). https://doi.org/10.1038/s41598-021-87703-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-87703-z
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
